Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|January 21, 2021
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL)Carola Boccomini, Marco Ladetto, Luigi Rigacci, et al.
Leukemia & Lymphoma|January 2, 2024
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategiesSimonetta Viviani, Anna Vanazzi, Samuele Frassoni, et al.
Haematologica|November 26, 2013
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana LinfomiMichele Merli, Carlo Visco, Michele Spina, et al.
European Journal of Haematology|June 17, 2020
Primary pancreatic lymphoma: Clinical presentation, diagnosis, treatment, and outcomeDavide Facchinelli, Sokol Sina, Enrico Boninsegna, et al.
The Lancet. Haematology|February 22, 2017
Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trialAndrés J M Ferreri, Marianna Sassone, Francesco Zaja, et al.
Leukemia & Lymphoma|May 31, 2017
Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimusGeorg Hess, Simon Rule, Wojciech Jurczak, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 28, 2017
Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative StudyColette Zwarthoed, Tarec Cristoffer El-Galaly, Maria Canepari, et al.
Hematological Oncology|February 7, 2019
Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical networkSara Rattotti, Virginia Valeria Ferretti, Chiara Rusconi, et al.
Lancet (London, England)|December 18, 2015
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 studyMartin Dreyling, Wojciech Jurczak, Mats Jerkeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2017
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular LymphomaStefano Luminari, Angela Ferrari, Martina Manni, et al.
Pageof 6